Maternal and pediatric populations have historically been considered “therapeutic orphans”
due to their limited inclusion in clinical trials. Physiologic changes during pregnancy and …

BACKGROUND Mental health worsened in adolescents and young adults after the
coronavirus disease 2019 (COVID-19) outbreak in March 2020, but whether antidepressant …

Since the onset of the COVID-19 pandemic, there have been concerns over the mental
health impact of COVID-19. This is a review of the utilization of antidepressants, anxiolytics …

Objectives Healthcare utilization decreased during the COVID-19 pandemic, likely due to
reduced transmission of infections and healthcare avoidance. Though various investigations …

Objective: Increased mental health problems among children and adolescents during the
COVID-19 pandemic may have impacted psychotropic medication use. This study describes …

Video Abstract OBJECTIVE To evaluate changes in prescription stimulant dispensing to
children aged 5 to 17 years associated with the COVID-19 pandemic and the shortage of …

Objective To provide updated national prevalence estimates of diagnosed attention-
deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt of …

Background No national study has evaluated changes in the appropriateness of US
outpatient antibiotic prescribing across all conditions and age groups after the coronavirus …

The containment measures following COVID-19 pandemic drastically reduced airway
infections, but they also limited the access of patients to healthcare services. We aimed to …

Methods Using electronic health record data from a pediatric primary care network that cares
for∼ 375 000 children in Massachusetts, we calculated the incidence of 9 common …